Mark A. Morse

3.6k total citations
74 papers, 2.9k citations indexed

About

Mark A. Morse is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Mark A. Morse has authored 74 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 18 papers in Cancer Research and 11 papers in Organic Chemistry. Recurrent topics in Mark A. Morse's work include Genomics, phytochemicals, and oxidative stress (33 papers), Glutathione Transferases and Polymorphisms (14 papers) and Carcinogens and Genotoxicity Assessment (12 papers). Mark A. Morse is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (33 papers), Glutathione Transferases and Polymorphisms (14 papers) and Carcinogens and Genotoxicity Assessment (12 papers). Mark A. Morse collaborates with scholars based in United States, Netherlands and India. Mark A. Morse's co-authors include Gary D. Stoner, Gary D. Stoner, Shantu Amin, Fung‐Lung Chung, Karin I. Eklind, Stephen S. Hecht, Fung Lung Chung, Laura A. Kresty, Jerry Lu and Gary J. Kelloff and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mark A. Morse

72 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Morse United States 28 2.0k 531 466 434 401 74 2.9k
Guoxiang Shen United States 29 3.1k 1.5× 438 0.8× 492 1.1× 265 0.6× 445 1.1× 40 4.2k
C. Clifford Conaway United States 27 1.9k 0.9× 432 0.8× 540 1.2× 399 0.9× 217 0.5× 44 2.6k
Vidya Hebbar United States 23 2.0k 1.0× 344 0.6× 402 0.9× 155 0.4× 414 1.0× 24 2.7k
Patrick M. Dolan United States 18 2.4k 1.2× 408 0.8× 486 1.0× 228 0.5× 186 0.5× 28 3.1k
André Castonguay Canada 31 1.4k 0.7× 245 0.5× 360 0.8× 785 1.8× 178 0.4× 113 2.9k
Emerich S. Fiala United States 33 1.9k 0.9× 296 0.6× 199 0.4× 759 1.7× 249 0.6× 89 3.6k
Eun‐Ryeong Hahm United States 35 1.8k 0.9× 447 0.8× 288 0.6× 385 0.9× 159 0.4× 84 3.2k
Luke K. T. Lam United States 28 1.2k 0.6× 502 0.9× 345 0.7× 274 0.6× 240 0.6× 56 2.3k
Jen-Kun Lin Taiwan 31 1.6k 0.8× 514 1.0× 235 0.5× 402 0.9× 855 2.1× 45 3.7k
Makoto Asamoto Japan 33 1.7k 0.8× 345 0.6× 149 0.3× 805 1.9× 290 0.7× 126 3.3k

Countries citing papers authored by Mark A. Morse

Since Specialization
Citations

This map shows the geographic impact of Mark A. Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Morse more than expected).

Fields of papers citing papers by Mark A. Morse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Morse. The network helps show where Mark A. Morse may publish in the future.

Co-authorship network of co-authors of Mark A. Morse

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Morse. A scholar is included among the top collaborators of Mark A. Morse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Morse. Mark A. Morse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gopalakrishnan, Rajaram, Ashok Gupta, Peter S. Carlton, Mark A. Morse, & Gary D. Stoner. (2002). FUNCTIONAL ROLE OF CYTOCHROME P-450 2A3 IN N -NITROSOMETHYLBENZYLAMINE METABOLISM IN RAT ESOPHAGUS. Journal of Toxicology and Environmental Health. 65(15). 1077–1091. 5 indexed citations
3.
Gupta, Amod, Peter S. Carlton, Diana L. Gray, et al.. (2001). Effects of Dietary N-(4-Hydroxyphenyl)retinamide on N-Nitrosomethylbenzylamine Metabolism and Esophageal Tumorigenesis in the Fischer 344 Rat. JNCI Journal of the National Cancer Institute. 93(13). 990–998. 10 indexed citations
4.
Hudson, Tamaro, et al.. (2001). Investigation of the enhancement of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis by 6-phenylhexyl isothiocyanate. Cancer Letters. 162(1). 19–26. 5 indexed citations
5.
Gopalakrishnan, Rajaram, Mark A. Morse, Jerry Lu, et al.. (1999). Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine. Carcinogenesis. 20(5). 885–891. 31 indexed citations
6.
Steele, Vernon E., Donya Bagheri, Douglas A. Balentine, et al.. (1999). Preclinical Efficacy Studies of Green and Black Tea Extracts. Proceedings of The Society for Experimental Biology and Medicine. 220(4). 210–212. 29 indexed citations
7.
Hughes, Steven J., Mark A. Morse, Christopher M. Weghorst, et al.. (1999). Cytochromes P450 are Expressed in Proliferating Cells in Barrett's Metaplasia. Neoplasia. 1(2). 145–153. 25 indexed citations
8.
Morse, Mark A. & Jerry Lu. (1998). High-performance liquid chromatographic method for measurement of cytochrome P450-mediated metabolism of 7-ethoxy-4-trifluoromethylcoumarin. Journal of Chromatography B Biomedical Sciences and Applications. 708(1-2). 290–293. 14 indexed citations
9.
Stoner, Gary D., Mark A. Morse, & Gary J. Kelloff. (1997). Perspectives in cancer chemoprevention.. Environmental Health Perspectives. 105(suppl 4). 945–954. 70 indexed citations
11.
Morse, Mark A., et al.. (1996). Inhibition of metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by limonene. Cancer Letters. 104(2). 211–217. 14 indexed citations
12.
Stoner, Gary D. & Mark A. Morse. (1996). Isothiocyanates as Inhibitors of Esophageal Cancer. Advances in experimental medicine and biology. 401. 13–23. 9 indexed citations
13.
Morse, Mark A., et al.. (1995). Failure of dietary oltipraz to inhibit benzo[α]pyrene-induced lung tumorigenesis in strain a mice. Cancer Letters. 91(1). 133–138. 13 indexed citations
14.
Caporaso, Neil E., Jean Whitehouse, Haleem J. Issaq, et al.. (1994). In vitro but not in vivo inhibition of CYP2D6 by phenethyl isothiocyanate (PEITC), a constituent of watercress. Pharmacogenetics. 4(5). 275–280. 9 indexed citations
15.
Chung, Fung‐Lung, Mark A. Morse, Karin I. Eklind, & Yong‐Zhen Xu. (1993). Inhibition of the Tobacco‐Specific Nitrosamine‐Induced Lung Tumorigenesis by Compounds Derived from Cruciferous Vegetables and Green Teaa. Annals of the New York Academy of Sciences. 686(1). 186–201. 50 indexed citations
18.
Morse, Mark A., Karin I. Eklind, Shantu Amin, & Fung‐Lung Chung. (1992). Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice. Cancer Letters. 62(1). 77–81. 33 indexed citations
20.
Fossa, Anthony A., et al.. (1986). Binding and distribution studies in the SENCAR mouse of compounds demonstrating a route-dependent tumorigenic effect.. Environmental Health Perspectives. 68. 53–60. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026